Search

Your search keyword '"Ziegler, Alban"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Ziegler, Alban" Remove constraint Author: "Ziegler, Alban" Search Limiters Full Text Remove constraint Search Limiters: Full Text
146 results on '"Ziegler, Alban"'

Search Results

2. Missense variants in ANO4 cause sporadic encephalopathic or familial epilepsy with evidence for a dominant-negative effect

3. TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease

4. The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant

5. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids.

6. Accelerated genome sequencing with controlled costs for infants in intensive care units: a feasibility study in a French hospital network

7. Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish

9. Mono and biallelic variants in HCN2 cause severe neurodevelopmental disorders

10. Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND)

11. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis

13. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation

14. Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders

16. O35: Feasibility of expanded newborn screening using genome sequencing for early actionable conditions in a diverse city

17. Loss-of-function variants in CUL3 cause a syndromic neurodevelopmental disorder

18. Bi-allelic variants in DOHH, catalyzing the last step of hypusine biosynthesis, are associated with a neurodevelopmental disorder

19. Prenatal diagnosis by trio exome sequencing in fetuses with ultrasound anomalies: A powerful diagnostic tool

20. The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing

21. Pathogenic variants in SMARCA1 cause an X-linked neurodevelopmental disorder modulated by NURF complex composition

22. Identification of novel compound heterozygous variants in the SLC30A7 (ZNT7) gene in two French brothers with stunted growth, testicular hypoplasia and bone marrow failure

23. Variants in PHF8 cause a spectrum of X-linked neurodevelopmental disorders and facial dysmorphology

24. Correction: The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis

25. SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile

27. Variants in PHF8 cause a spectrum of X-linked neurodevelopmental disorders and facial dysmorphology

28. Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder

29. FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy

30. FC044: Heterozygous Variants in Kinase Domain of NEK8 cause an Autosomal-Dominant Ciliopathy

31. Biallelic variants in HECT E3 paralogs, HECTD4 and UBE3C, encoding ubiquitin ligases cause neurodevelopmental disorders that overlap with Angelman syndrome

32. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

33. Accelerated genome sequencing with controlled costs for infants in intensive care units: a feasibility study in a French hospital network

34. Clinical and molecular delineation of PUS3‐associated neurodevelopmental disorders

35. Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders

36. Bi-allelic variants in IPO8 cause a connective tissue disorder associated with cardiovascular defects, skeletal abnormalities, and immune dysregulation

37. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

38. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

39. Variants in USP48 encoding ubiquitin hydrolase are associated with autosomal dominant non-syndromic hereditary hearing loss

40. Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders.

41. Use of Next-Generation Sequencing for the Molecular Diagnosis of 1,102 Patients With a Autosomal Optic Neuropathy

42. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis

43. Correction: The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis

44. Congenital hypothyroidism and hearing loss without inner ear malformation: Think TPO

45. Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome

46. De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features

47. Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development

48. De novo and inherited variants in ZNF292 underlie a neurodevelopmental disorder with features of autism spectrum disorder

49. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum

50. De novo missense variants in LMBRD2 are associated with developmental and motor delays, brain structure abnormalities and dysmorphic features.

Catalog

Books, media, physical & digital resources